| Date Filed | Type | Description |
| 12/14/2020 |
GN
| Cerevel Therapeutics to Host Inaugural Virtual R&D Event |
| 12/08/2020 |
GN
| Cerevel Therapeutics Announces the Appointment of Dr. Ruth McKernan to its Board of Directors |
| 11/23/2020 |
GN
| Cerevel Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference |
| 11/16/2020 |
GN
| Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights |
| 11/04/2020 |
GN
| Cerevel Therapeutics to Present at Upcoming Virtual Investor Conferences |
| 10/30/2020 |
GN
| Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson's Disease |
| 08/16/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 08/05/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/05/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/05/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/03/2016 |
4
| Hamilton Richard William (President and CEO) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
4
| Goldberg Robert Bruce (Director) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
4
| Flavell Richard Bailey (Director) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
4
| Brandys Pascal (Director) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
4
| van Assche Wilfriede Margareta Maria (SVP & Gen. Counsel & Secretary) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/03/2016 |
4
| Kuc Paul (CFO) has filed a Form 4 on Ceres, Inc. |
| 08/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/03/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 08/01/2016 |
8-K
| Quarterly results |
| 08/01/2016 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/01/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 08/01/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 07/22/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 07/18/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 07/15/2016 |
8-K
| Form 8-K - Current report |
| 07/15/2016 |
10-Q
| Quarterly Report for the period ended May 31, 2016 |
| 07/13/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 07/06/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 07/01/2016 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 07/01/2016 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 06/30/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 06/17/2016 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
|